Gonorrhea and Pelvic Inflammatory Disease: Complications, Fertility Impact, and Prevention

Neisseria gonorrhoeae ascends from the cervix to the upper genital tract in 10–20% of untreated women, causing pelvic inflammatory disease (PID). PID triggers inflammation, fibrosis, and scarring of the fallopian tubes, ovaries, and uterus.

Severe Sequelae

  • Tubal factor infertility: Bilateral tubal occlusion — 10–15% after 1 PID episode, 35% after 2, 75% after 3.
  • Ectopic pregnancy: 6–10× increased risk due to impaired tubal transport.
  • Chronic pelvic pain: Adhesions, nerve entrapment — 18–30% of PID survivors.
  • Tubo-ovarian abscess (TOA): Requires IV antibiotics ± drainage; may necessitate salpingo-oophorectomy.
  • Hysterectomy: Rare, for uncontrolled TOA, hemorrhage, or refractory pain.

Critical Window

Treatment within 48–72 hours of symptom onset drastically reduces long-term damage. CDC regimen: Ceftriaxone 500 mg IM (1 g if ≥150 kg) + Doxycycline 100 mg BID × 7 days ± Metronidazole.

Prevention

  • Annual screening (NAAT) for sexually active women <25, and older with risk factors.
  • Expedited partner therapy (EPT) where legal.
  • Condoms reduce transmission ~90%.
  • Vaccination: HPV (not gonorrhea, but co-prevention).

Early detection and guideline-concordant treatment preserve fertility. Asymptomatic infection is common—screening is essential.

Gonorrhea - Related Articles